Leibel RL, Rosenbaum M, Hirsch J
The problem: Youve heard that semaglutide may increase the risk of bone loss, which is a serious problem for older adults at higher risk of osteoporosis
Morphological abnormalities such as mitochondrial swelling, cristae disruptions, and structural irregularities, coupled with reduced ATP levels and heightened ROS production, are observed in ovarian aging across various oocyte species, indicating compromised clearance processes [153, 291]
So, we talk about the lock-in effect a lot, and it's kind of easy to point to
If you're dosing every five to six days instead of seven, you'll run through your monthly supply faster and may face gaps where you can't inject on schedule
Hormone Therapy and HRT Support Through Gala GLP-1 Gala GLP-1's hormone health program is designed for women navigating perimenopause and beyond - a stage of life where hormonal shifts can affect sleep, mood, weight, bone density, and energy, often without a clear clinical pathway to address them